Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thorax

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2010.136994PMID 20696691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pleurodesis for malignant pleural effusions.

  2013cited by this paper
• Thorax

  2009cited by this paper
• Efficacy of Iodopovidone Pleurodesis and Comparison of Small-Bore Catheter Versus Large-Bore Chest Tube

  2008cited by this paper
• Management of Malignant Pleural Effusion Associated with Trapped Lung Syndrome

  2008cited by this paper
• Management of Malignant Pleural Effusions

  2008cited by this paper
• Management of malignant pleural effusions using the Pleur(x) catheter.

  2008cited by this paper
• Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.

  2007cited by this paper
• A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.

  2007cited by this paper
• Malignant pleural effusions: review of treatment and our experience.

  2007cited by this paper
• Prise en charge des pleurésies néoplasiques par insertion d’un catheter pleural tunnellisé. Une approche ambulatoire exclusive ?

  2007cited by this paper
• Catheter-tract metastases associated with chronic indwelling pleural catheters.

  2007cited by this paper
• The relationship of pleural pressure to symptom development during therapeutic thoracentesis.

  2006influential reference
• Intrapleural Urokinase for the Treatment of Loculated Malignant Pleural Effusions and Trapped Lungs in Medically Inoperable Cancer Patients

  2006cited by this paper
• Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.

  2006cited by this paper
• Needle-track metastases and prophylactic radiotherapy for mesothelioma.

  2006cited by this paper
• Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy.

  2006cited by this paper
• Thoracoscopic palliative treatment of malignant pleural effusions

  2006cited by this paper
• Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.

  2006cited by this paper
• Video‐assisted management of malignant pleural effusion in breast carcinoma

  2006cited by this paper
• The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.

  2006cited by this paper
• Erratum: Gasparri R, Leo F, Veronesi G, et al. Video‐assisted management of malignant pleural effusion in breast carcinoma. Cancer. 2006; 106(2):271–6.

  2006cited by this paper
• Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.

  2006cited by this paper
• Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis.

  2006cited by this paper
• Management of Recurrent Malignant Pleural Effusion with Chemical Pleurodesis

  2005cited by this paper
• Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.

  2005cited by this paper
• Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

  2005cited by this paper
• Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.

  2005influential reference
• Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.

  2005cited by this paper
• Malignant pleural effusion.

  2005cited by this paper
• Bleomycin pharmacokinetics in man

  2004cited by this paper
• Pleurodesis in Patients with Malignant Pleural Effusions: Talc Slurry or Bleomycin? Results of a Prospective Randomized Trial

  2004cited by this paper
• Incidence of incisional recurrence after thoracoscopy

  2004cited by this paper
• Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis.

  2004cited by this paper
• Pleurodesis in Patients with Malignant Pleural Effusions: Talc Slurry or Bleomycin? Results of a Prospective Randomized Trial

  2004cited by this paper
• A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma

  2004cited by this paper
• Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.

  2004cited by this paper
• Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial.

  2003cited by this paper
• Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions.

  2003cited by this paper
• Arterial Desaturation Syndrome Following Pleurodesis with Talc Slurry: Incidence, Clinical Features, and Outcome

  2003cited by this paper
• Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis.

  2002cited by this paper
• Early and late mortality after pleurodesis for malignant pleural effusion.

  2002cited by this paper
• Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis.

  2002cited by this paper
• Distribution of calibrated talc after intrapleural administration: an experimental study in rats.

  2002cited by this paper
• Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.

  2002cited by this paper
• Thoracoscopy talc poudrage : a 15-year experience.

  2001cited by this paper
• Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.

  2001cited by this paper
• Serious complications with talc slurry pleurodesis

  2001cited by this paper
• Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions

  2001cited by this paper
• Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.

  2001cited by this paper
• Talc preparations used for pleurodesis vary markedly from one preparation to another.

  2001cited by this paper
• A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions

  2000cited by this paper
• Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients

  2000cited by this paper
• Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Discussion

  2000cited by this paper
• Intrapleural palliative treatment of malignant pleural effusions with talcum versus placebo (pleural tube alone)

  2000cited by this paper
• Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.

  2000cited by this paper
• Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.

  2000cited by this paper
• Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.

  2000cited by this paper
• Intrapleural streptokinase in the management of malignant multiloculated pleural effusions.

  1999cited by this paper
• Using urokinase to treat malignant pleural effusions.

  1999cited by this paper
• Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.

  1999cited by this paper
• Respiratory failure following talc pleurodesis.

  1999cited by this paper
• Systemic distribution of talc after intrapleural administration in rats.

  1999cited by this paper
• Pathogenesis of Malignant Pleural Effusions and Talc Pleurodesis1

  1999cited by this paper
• Systemic corticosteroids decrease the effectiveness of talc pleurodesis.

  1998cited by this paper
• Clinical Investigations: The PleuraSclerotherapy for Malignant Pleural Effusions: A Prospective Randomized Trial of Bleomycin vs Doxycycline with Small-Bore Catheter Drainage

  1998cited by this paper
• Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study.

  1998cited by this paper
• Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions.

  1998cited by this paper
• Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion.

  1998cited by this paper
• Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V. sedation.

  1998cited by this paper
• Pleurodesis with Iodized Talc for Malignant Effusions Using Pigtail Catheters

  1998cited by this paper
• Therapeutic thoracoscopy.

  1998cited by this paper
• Clinical Investigations: CancerThoracoscopic Talc Poudrage in Malignant Pleural Effusions: Effective Pleurodesis Despite Low Pleural pH

  1998cited by this paper
• Thoracoscopy--state of the art.

  1998cited by this paper
• A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions.

  1997cited by this paper
• Pleural diseases related to metastatic malignancies.

  1997cited by this paper
• As originally published in 1988: Reexpansion pulmonary edema. Updated in 1997.

  1997cited by this paper
• Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin.

  1997cited by this paper
• Respiratory failure due to insufflated talc.

  1997cited by this paper
• Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions.

  1997cited by this paper
• Underwater seal chest drains: the patient's experience.

  1997cited by this paper
• The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: A prospective study

  1996cited by this paper
• How should cancer presenting as a malignant pleural effusion be managed?

  1996cited by this paper
• Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline: A comparison of bleomycin or tetracycline alone versus a combination of bleomycin and tetracycline

  1996cited by this paper
• Ambulatory sclerotherapy for malignant pleural effusions.

  1996cited by this paper
• Optimal therapy of malignant pleural effusions.

  1996cited by this paper
• Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.

  1996cited by this paper
• Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.

  1996cited by this paper
• Reexpansion Pulmonary Edema

  1996cited by this paper
• Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.

  1995cited by this paper
• Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.

  1995cited by this paper
• Failure of talc pleurodesis is associated with increased pleural fibrinolysis.

  1995cited by this paper
• The diagnostic and therapeutic utility of thoracoscopy. A review.

  1995cited by this paper
• Pulmonary Physiologic Abnormalities Caused by Pleural Disease

  1995cited by this paper
• Parietal pleurectomy for malignant pleural effusion

  1995cited by this paper
• Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy.

  1995cited by this paper
• Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy.

  1995cited by this paper
• Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.

  1994cited by this paper
• Day-case anaesthesia and sedation

  1994cited by this paper
• Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients.

  1994cited by this paper
• Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema.

  1994cited by this paper

• Role of trans thoracic ultrasonography in pleurodesis for malignant pleural effusion

  2026cites this paper
• Deep learning for malignancy and tumor origin prediction using cytology or histopathology whole slide images

  2026cites this paper
• Emerging immunotherapeutic strategies for malignant serous effusions: current evidence and future directions

  2026cites this paper
• Diagnostic sensitivity: Surgical biopsy versus minimally invasive techniques in bronchopulmonary cancer.

  2026cites this paper
• Talc pleurodesis versus indwelling pleural catheter for refractory pleural effusion: a prospective study of survival and complications.

  2026cites this paper
• Integrating pleural PD-1+CD8+ T cell as a complement variable into LENT score to assess patients with lung adenocarcinoma complicated with MPE.

  2026cites this paper
• Pleuraerguss – rationale Diagnostik

  2026cites this paper
• Management des Malignen Pleuraergusses – Thorakoskopie in Lokalanästhesie ohne Bedeutung?

  2026cites this paper
• Emergency decompression of rare tension hydrothorax with obstructive shock: a case series

  2025influential citation
• Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores

  2025cites this paper
• Exploring prognostic precision: a nomogram approach for malignant pleural effusion in lung cancer

  2025cites this paper
• 恶性胸腔积液局部治疗研究进展

  2025cites this paper
• Surface-enhanced Raman spectroscopy (SERS) metabolite profiling of pleural fluid

  2025cites this paper
• Diagnostic value of pleural fluid neuron-specific enolase for malignant pleural effusion

  2025cites this paper
• Prognostic factors and treatment outcomes in EGFR-mutated NSCLC with malignant pleural effusion: focus on intrathoracic chemotherapy and EGFR-TKI therapy

  2025cites this paper
• External validation of the LENT and PROMISE prognostic scores for malignant pleural effusion

  2025cites this paper
• Treatment of Malignant Pleural Effusions.

  2025cites this paper
• Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective

  2025cites this paper
• Management of Malignant Pleural Effusion in 2024: A Definitive and Unified Global Approach.

  2025cites this paper
• Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review.

  2025cites this paper
• "Not-So-Simple": Rethinking Pleural Effusions in Cancer, Heart Failure, and Pneumonia.

  2025cites this paper
• Accuracy of Fully Automated and Human-assisted AI-based CT Quantification of Pleural Effusion Changes after Thoracentesis.

  2025cites this paper
• The utility of a pleural carcinomatosis score for assessing resectability

  2025cites this paper
• Clinical Significance and Prognosis of Non-Expandable Lungs in Patients with Unilateral Pleural Effusion

  2025influential citation
• Systemwide Implementation of a Multidisciplinary Clinical Pathway for Malignant Pleural Effusion Reduces Interventions, Hospitalizations, and Costs.

  2025cites this paper
• Pleurapunktion – Schritt für Schritt

  2025cites this paper
• Predictors of Survival in Metastatic Malignant Pleural Effusions: The GASENT Score.

  2025cites this paper
• Novel bioengineered drugs with immunotherapies for malignant pleural effusion: remodulate tumor immune microenvironment and activate immune system.

  2025cites this paper
• A potential target for the future treatment of malignant pleural effusion: Monocyte chemoattractant protein-1 (MCP-1)

  2025cites this paper
• Case Report: Ivonescimab in EGFR-mutant lung cancer with baseline malignant pleural effusion and acquired complex resistance

  2025cites this paper
• Utility of Emerging Novel Criteria “Cancer Ratio” and “Cancer Ratio Plus” in Differentiating Malignant from Nonmalignant Pleural Effusions

  2025cites this paper
• The association of defective pleural sRAGE production with the recurrence of malignant pleural effusion after Talc pleurodesis

  2025cites this paper
• Updates in the management of malignant pleural effusion: a clinical practice review

  2025cites this paper
• Management des malignen Pleuraergusses

  2025cites this paper
• The Evolution of the Indwelling Pleural Catheter

  2025cites this paper
• Nötrofil-Lenfosit Oranı ve LENT Skorunun Malign Plevral Efüzyonlarda Prognoza Etkisi

  2025cites this paper
• Influences of age and sex on the diagnostic accuracy of human epididymis secretory protein 4 for malignant pleural effusion

  2025cites this paper
• Diagnostic Accuracy of Shear Wave Elastography in Predicting Malignant Origins of Pleural Effusions in Emergency Departments

  2025cites this paper
• Conservative management of spontaneous pneumothorax: A review of evidence and guidelines

  2025cites this paper
• Pleural Space Diseases and Their Management: What is the Role of Intrapleural Fibrinolytic Therapy?

  2025cites this paper
• Oncolytic viruses: a promising therapy for malignant pleural effusion and solid tumors

  2025cites this paper
• Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors

  2025cites this paper
• Use of a novel ultrasound sign in the management of malignant pleural effusions: a prospective observational trial.

  2025cites this paper
• Psychosocial impact of living with an indwelling pleural catheter in patients with malignant pleural effusions: a thematic analysis

  2025cites this paper
• Pleural fluid human epididymis secretory protein 4 in differentiating between malignant and benign pleural effusions: a systematic review and meta-analysis

  2025cites this paper
• Diagnostic accuracy of pleural fluid carbohydrate antigen 72-4 for malignant pleural effusion: a systematic review and meta-analysis

  2025cites this paper
• Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non‐Expandable Lungs

  2025cites this paper
• Indwelling pleural catheters for the treatment of malignant pleural effusions; where are we now?

  2025cites this paper
• Efficacy of a Fully Implantable Pleural Device in the Management of Complex Pleural Effusions

  2025cites this paper
• Management des malignen Pleuraergusses

  2025cites this paper
• Biomaterial-based drug delivery systems for the therapy of malignant pleural effusion

  2025cites this paper
• Risk Factors Affecting Spontaneous Pleurodesis After Indwelling Tunneled Catheter Application in Malignant Pleural Effusion

  2025cites this paper
• Thoracic Ultrasound for Pre-Procedural Dynamic Assessment of Non-Expandable Lung: A Non-Invasive, Real-Time and Multifaceted Diagnostic Tool

  2025cites this paper
• Prognostic Value of Surgical Resection for Non-small-cell Lung Cancer Patients Comorbid With Minimal Pleural Effusion

  2025cites this paper
• Re-expansion pulmonary oedema: two case reports and review of the current literature

  2024cites this paper
• The diagnostic accuracy of HE4 in the differential diagnosis of pleural effusions.

  2024cites this paper
• Prognostic Role of Pleural Fluid SUVpeak Value obtained from 18F-FDG PET/CT in patients with Malignant Pleural Effusion.

  2024cites this paper
• Beyond tradition: Exploring the potential of a novel drainage technique for indwelling pleural catheter

  2024cites this paper
• Rapid Pleurodesis in Patients With Chronic Noninfectious Pleural Effusion

  2024cites this paper
• Efficacious Factors in Pleural Malignancy Based on Characteristics of Pleural Fluid and Type of Primary Tumor in Shahid Sadouqhi and Shahid Rahmonun Hospitals of Yazd from 2019 to 2021

  2024cites this paper
• Gestione chirurgica dei versamenti pleurici recidivanti

  2024cites this paper
• Malignant Pleural Effusion: Diagnosis and Treatment—Up-to-Date Perspective

  2024cites this paper
• Chest tube size selection for pleural effusion: from the perspective of thoracic surgeons and pulmonologists

  2024cites this paper
• Complete response and long-term survival to endocrine monotherapy in a patient with metastatic breast cancer in a low-income country: a case report

  2024cites this paper
• Comparison of five scores to predict mortality in malignant pleural effusion

  2024cites this paper
• The value of computed tomography-based radiomics for predicting malignant pleural effusions

  2024cites this paper
• Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research

  2024influential citation
• EGFR mutations in patients with lung adenocarcinoma and malignant pleural effusion: a propensity score-matched analysis of a single-center database

  2024cites this paper
• Talc slurry versus thoracoscopic talc insufflation for malignant pleural effusion: a systematic review and meta-analysis

  2024cites this paper
• Pleural pro-gastrin releasing peptide is a potential diagnostic marker for malignant pleural effusion induced by small-cell lung cancer

  2024cites this paper
• Characterizing Risk Factors Associated With Recurrent Pleural Effusions in the Lung Transplant Recipients

  2024cites this paper
• Thoracic ultrasound in guiding management of respiratory disease

  2024cites this paper
• Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology

  2024cites this paper
• Enhancing Intrapleural Hyperthermic Chemotherapy for Lung Cancer: Insights from 3D and PDX Models

  2024cites this paper
• Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations – From an Expert Panel

  2024cites this paper
• The rapidly changing field of predictive biomarkers of non-small cell lung cancer

  2024cites this paper
• Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions.

  2024cites this paper
• Management des malignen Pleuraergusses

  2024cites this paper
• The role of day-case thoracoscopy at a district general hospital: A real world observational study

  2024cites this paper
• Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

  2024cites this paper
• Role of cancer ratio (serum LDH/pleural ADA) and carcinoembryonic antigen in diagnosis of malignant pleural effusion

  2024cites this paper
• Factors Associated with Procedure-related Tumor Seeding in Advanced Stage Lung Cancer Patients with Malignant Pleural Effusions

  2024cites this paper
• Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency

  2024cites this paper
• Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.

  2024cites this paper
• Pictorial Review of Pleural Disease: Multimodality Imaging and Differential Diagnosis.

  2024cites this paper
• Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test

  2024cites this paper
• Nonexpandable Lung

  2024cites this paper
• Comparison between Rapid and Standard procedure Pleurodesis outcome in Malignant Pleural Effusion

  2024cites this paper
• Indwelling tunneled pleural catheter infections and host related factors.

  2024cites this paper
• Usefulness of thoracic ultrasound in the assessment of removal of indwelling pleural catheter in patients with malignant pleural effusion.

  2024cites this paper
• Complications of Palliative Interventions for Malignant Pleural Effusions

  2024cites this paper
• Validating LENT score in malignant pleural effusion

  2024cites this paper
• Medical thoracoscopy with cryobiopsy as diagnostic tool for pleural metastatic in cutaneous squamous cell carcinoma: a rare case report

  2024cites this paper
• Development of a diagnostic algorithm to ascertain malignant pleural effusion utilizing clinical indicators and serum metal concentrations

  2024cites this paper
• Comparison of thoracostomy tube size with pleural fluid dynamics in serous and hemorrhagic fluid models: an experimental study

  2024cites this paper
• [Treatment of malignant effusion].

  2024cites this paper
• Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study

  2024cites this paper
• The 2023 British Thoracic Society Guideline for Pleural Disease Update on Malignant Pleural Effusion

  2024cites this paper
• Prolonged Non-Steroidal Anti-Inflammatory Drug Exposure After Pleurodesis Increases Pneumothorax Recurrence: A Retrospective Cohort Study.

  2024cites this paper
• Ultrasound in the Diagnosis of Non-Expandable Lung: A Prospective Observational Study of M-Mode, B-Mode, and 2D-Shear Wave Elastography

  2024cites this paper